Health Care FinancePart D/Prescription Drugs

Congress considers 340B changes

(By Emily Rappleye for Becker’s Hospital Review)

The House reviewed 15 bills July 11 that would revamp the oversight, transparency and organization of the 340B Drug Discount Program.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

 

Leave a Reply